Document Detail

Insulitis in type 2 diabetes.
MedLine Citation:
PMID:  18834448     Owner:  NLM     Status:  MEDLINE    
Islets of patients with type 2 diabetes have the feature of an inflammatory process reflected by the presence of cytokines, immune cells, beta-cell apoptosis, amyloid deposits and fibrosis. Indeed, beta-cells from patients with type 2 diabetes display inflammatory markers, including increased interleukin (IL)-1 beta expression. Furthermore, increased islet-associated macrophages are observed in human type 2 diabetic patients and in most animal models of diabetes. Importantly, increased numbers of macrophages are detectable very early in high fat-fed mice islets, before the onset of diabetes. These immune cells are most likely attracted by islet-derived chemokines, produced in response to metabolic stress, and under the control of IL-1 beta. It follows that modulation of intra-islet inflammatory mediators, in particular IL-1 beta, may prevent insulitis in type 2 diabetes and therefore presents itself as a possible causal therapy with disease-modifying potential.
M Böni-Schnetzler; J A Ehses; M Faulenbach; M Y Donath
Related Documents :
7199058 - Elevated plasma beta-hydroxybutyrate concentrations without ketonuria in healthy insuli...
6337048 - Effect of beta-casomorphins and analogs on insulin release in dogs.
20719858 - Fructose-1,6-bisphosphatase regulates glucose-stimulated insulin secretion of mouse pan...
117878 - Role of residual insulin secretion in protecting against ketoacidosis in insulin-depend...
21659498 - The rankl/rank/opg signaling pathway mediates medial arterial calcification in diabetic...
22188858 - Ischemic stroke and glucose intolerance: a review of the evidence and exploration of no...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Diabetes, obesity & metabolism     Volume:  10 Suppl 4     ISSN:  1463-1326     ISO Abbreviation:  Diabetes Obes Metab     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2008-10-06     Completed Date:  2008-12-09     Revised Date:  2009-11-03    
Medline Journal Info:
Nlm Unique ID:  100883645     Medline TA:  Diabetes Obes Metab     Country:  England    
Other Details:
Languages:  eng     Pagination:  201-4     Citation Subset:  IM    
Clinic of Endocrinology and Diabetes and Centre for Integrated Human Physiology, University Hospital of Zurich, Zurich, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Apoptosis / physiology
Diabetes Mellitus, Type 2 / immunology*,  metabolism
Glucagon / biosynthesis
Insulin / biosynthesis,  immunology*
Interleukin-1beta / immunology*,  metabolism
Islets of Langerhans / immunology*,  metabolism
Reg. No./Substance:
0/Interleukin-1beta; 11061-68-0/Insulin; 9007-92-5/Glucagon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Beta-cell development: the role of intercellular signals.
Next Document:  Cell therapy for type 2 diabetes: is it desirable and can we get it?